Research / ORCL / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-20-030125 General Corporate
Capex intensity 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.00% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
33.63% · OPTIONAL · VALID
Revenue growth 8th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
-1.11% · CORE · VALID
Inventory pressure 0th Own-history percentile · N=11
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
0.54% · OPTIONAL · VALID
Operating margin 94th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
35.57% · CORE · VALID
R&D intensity 41th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.53% · OPTIONAL · VALID
SBC intensity 53th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.07% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Nov 30, 2019 5/6 normalized Level 3 Feb 29, 2020 5/6 normalized Level 3 May 31, 2020 7/7 normalized Level 3 Aug 31, 2020 6/6 normalized Level 3 Nov 30, 2020 6/6 normalized Level 3 Feb 28, 2021 6/6 normalized Level 3 May 31, 2021 7/7 normalized Level 3 Aug 31, 2021 6/6 normalized Level 3 Nov 30, 2021 6/6 normalized Level 3 Feb 28, 2022 6/6 normalized Level 3 May 31, 2022 7/8 normalized Level 3 Aug 31, 2022 6/6 normalized Level 3 Nov 30, 2022 6/6 normalized Level 3 Feb 28, 2023 6/6 normalized Level 3 Aug 31, 2023 6/6 normalized Level 3 Nov 30, 2023 6/6 normalized Level 3 Feb 29, 2024 6/6 normalized Level 3 Aug 31, 2024 6/6 normalized Level 3 Nov 30, 2024 6/6 normalized Level 3 Aug 31, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 4.04%
Current 4.00%
Delta -0.04% Cash Generation Increased
Previous 30.75%
Current 33.63%
Delta 2.88% Growth Decreased
Previous 1.89%
Current -1.11%
Delta -3.00% Profitability Decreased
Previous 36.01%
Current 35.57%
Delta -0.45% R And D Intensity Increased
Previous 15.31%
Current 15.53%
Delta 0.22% Sbc Intensity Increased
Previous 3.69%
Current 4.07%
Delta 0.38% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.